Singapore markets closed

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.84+0.20 (+2.07%)
As of 11:48AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5336.72M
Enterprise value 3186.24M
Trailing P/E N/A
Forward P/E 1-4.75
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)9.80
Price/book (mrq)N/A
Enterprise value/revenue 35.42
Enterprise value/EBITDA 7-4.57

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-57.27%
S&P500 52-week change 339.21%
52-week high 358.37
52-week low 37.34
50-day moving average 39.38
200-day moving average 326.06

Share statistics

Avg vol (3-month) 31.55M
Avg vol (10-day) 3694.28k
Shares outstanding 534.22M
Implied shares outstanding 6N/A
Float 29.89M
% held by insiders 111.98%
% held by institutions 160.43%
Shares short (27 May 2021) 46.1M
Short ratio (27 May 2021) 49.29
Short % of float (27 May 2021) 424.88%
Short % of shares outstanding (27 May 2021) 417.84%
Shares short (prior month 29 Apr 2021) 45.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin -122.12%
Operating margin (ttm)-122.47%

Management effectiveness

Return on assets (ttm)-11.51%
Return on equity (ttm)-24.53%

Income statement

Revenue (ttm)34.37M
Revenue per share (ttm)1.04
Quarterly revenue growth (yoy)-36.00%
Gross profit (ttm)36.98M
EBITDA -40.78M
Net income avi to common (ttm)-41.97M
Diluted EPS (ttm)-10.29
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)194.91M
Total cash per share (mrq)5.7
Total debt (mrq)46.48M
Total debt/equity (mrq)26.20
Current ratio (mrq)10.58
Book value per share (mrq)-25.04

Cash flow statement

Operating cash flow (ttm)-61.3M
Levered free cash flow (ttm)-46.61M